Strikingly, the time window of TubA treatment was at least 24 hours after the ischemic onset, which is substantially longer than that of other HDAC inhibitors including the pan inhibitor valproate in ischemic stroke models18. The gene discussed is HDAC9; the disease is ischemic stroke.